Novo Nordisk
NVO
#22
Rank
C$569.25 B
Marketcap
$122.13
Share price
-17.83%
Change (1 day)
-9.76%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Market capitalization of Novo Nordisk (NVO)

Market cap: C$569.25 Billion

As of December 2024 Novo Nordisk has a market cap of C$569.25 Billion. This makes Novo Nordisk the world's 22th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novo Nordisk from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024C$569.25 B-6.94%
2023C$611.72 B48.05%
2022C$413.19 B27.11%
2021C$325.07 B56.34%
2020C$207.92 B14.43%
2019C$181.70 B19.3%
2018C$152.30 B-7.62%
2017C$164.86 B30.27%
2016C$126.55 B-40.1%
2015C$211.27 B61.65%
2014C$130.69 B21.34%
2013C$107.71 B19.08%
2012C$90.45 B33.31%
2011C$67.85 B0.5%
2010C$67.51 B58.51%
2009C$42.59 B7.52%
2008C$39.61 B-5.37%
2007C$41.86 B35.52%
2006C$30.89 B45.63%
2005C$21.21 B-2%
2004C$21.64 B17.97%
2003C$18.34 B15.45%
2002C$15.89 B-28.24%
2001C$22.14 B19.58%
2000C$18.51 B40.07%
1999C$13.22 B-10.8%
1998C$14.82 B-4.15%
1997C$15.46 B61%
1996C$9.60 B

End of Day market cap according to different sources

On Dec 20th, 2024 the market cap of Novo Nordisk was reported to be:

C$569.25 Billion
by Yahoo Finance info icon info icon
C$569.25 Billion
by CompaniesMarketCap info icon info icon
C$545.02 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$214.63 B-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$992.05 B 74.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$167.06 B-70.65%๐Ÿ‡บ๐Ÿ‡ธ USA
C$174.29 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France